Navigation Links
China Sky One Medical, Inc. Obtains SFDA Approval for Policresulen Vaginal Suppositories

HARBIN, China, March 12 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. (''China Sky One Medical'' or ''the Company'') (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China (''PRC''), today announced that it obtained approval from the State Food and Drug Administration (SFDA) in China for the production of Policresulen vaginal suppositories.

Policresulen vaginal suppositories are indicated for the treatment of cervical erosion, cervicitis, various vaginal inflammations resulting from bacteria, trichomoniasis or candidiasis, and for pressure ulcers due to vaginal pessary. The active ingredient in Policresulen vaginal suppositories is Policresulen, a topical haemostatic and antiseptic. This new product will be available to consumers around June of 2009.

''We are very pleased to receive SFDA approval in a timely manner, which continues to enable us to benefit from the increasing medical consumption in China tied to new health care reforms and a rising middle class,'' said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. ''We remain confident in our ability to identify drugs that have strong market potential that will enhance our portfolio.''

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company (''Jin Chuang'') the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Yu-Bo Hao, CFO
     Tel:   +86-451-5399-4069

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915

SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Pharma Holdings, Inc. to Host Fourth Quarter 2008 Earnings Conference Call at 8:30 a.m. EDT Wednesday March 18, 2009
2. China Yingxia International, Inc.s chairwoman and CEO is in talks with investors in China
3. China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date
4. Chindex International, Inc. to Participate in the Piper Jaffray & ChinaVenture Investment Conference 2009
5. China Shenghuo Announces Management Expansion and Enhanced Internal Controls
6. China Sky One Medical Inc. Gets SFDA Approval for Calcium Folinate Injection
7. China Nepstar Chain Drugstore to Announce Fourth Quarter and Fiscal 2008 Financial Results on March 16
8. University of the Rockies Faculty and Students Travel to China to Share Western Philosophy
9. QSAI & SGS-CSTC to Begin Joint Food Analysis Services in China
10. China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan
11. China Healthcare Acquisition Announces Record Date for Trust Fund Distribution
Post Your Comments:
(Date:10/13/2015)... Radnor, Pennsylvania (PRWEB) , ... October 13, 2015 ... ... and people through a unique private messaging application, announced today a significant contract ... for another five years. Independence plans to build on the growing success of ...
(Date:10/13/2015)... ST. LOUIS and CHENNAI, India (PRWEB) , ... October 13, 2015 ... ... the development of advanced camera solutions, today announced See3CAM_CU40, the industry’s first ... stand-alone MIPI CSI-2 module. See3CAM_CU40, a new member of e-con’s See3CAM family of UVC ...
(Date:10/13/2015)... Tenn. (PRWEB) , ... October 13, 2015 , ... A ... and that’s why SmileCareClub , the leading remote invisible aligner system, has joined ... who would otherwise go without it. For each aligner treatment plan purchased, SmileCareClub will ...
(Date:10/13/2015)... ... 2015 , ... Protein is essential to good health. You need it to ... how much protein does the average man need in order to stay healthy? ... 2015 issue of Harvard Men's Health Watch . Most Americans get about 15% ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... that targets the unique health needs of new moms. Postnatal Omega-3, which ... ( ), utilizes Nordic Naturals’ exclusive, new, ultra-concentrated omega-3 oil. This ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015  The ... Harvard University today announced the launch of ... Ultivue will introduce imaging reagents providing ... to those of expensive specialized instruments. The ... Harvard,s Office of Technology Development (OTD) ...
(Date:10/13/2015)... CARLOS, Calif. , Oct. 13, 2015   ... development advisory firm in Quantitative Systems Pharmacology (QSP)/ PhysioPD™ ... Chief Engineer, will lead a workshop at the ... 2015 in Boston, MA.  The ... in pharmaceutical drug development.  Dr. Friedrich,s workshop is entitled ...
(Date:10/13/2015)... , Oct. 8, 2015 Research and ... the "World Anti-counterfeit Pharmaceuticals and Cosmetics Packaging - ... to their offering. --> ... market to grow at a CAGR of 15.7% during ... The hologram authentication technology segment accounted for about 52% ...
Breaking Medicine Technology: